RxDoctor Payments Data

William Adair, MD

Family Medicine · Gettysburg, PANPI 1750407854

Payments from drug & device makers

$1,138in general payments, 2019–2025

Across 65 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$170
  • Amgen$150
  • Merck$138
  • Pfizer$130
  • Exact Sciences$119
  • Novo Nordisk$97
  • plus $335 from 11 others

What the payments were for

  • Food & beverage$1,138100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,138 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$670,503
Medicare patients
832
Services billed
21,821

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$155,760
RybelsusSemaglutide53$64,547
XareltoRivaroxaban39$58,736
ArexvyRsvpref3 Antigen/As01e/Pf171$53,806
JardianceEmpagliflozin40$35,542
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$34,655
MounjaroTirzepatide26$25,566
ProliaDenosumab11$18,496
OzempicSemaglutide11$12,177
GemtesaVibegron20$12,081
Fluticasone-SalmeterolFluticasone Propion/Salmeterol47$10,642
ShingrixVaricella-Zoster Ge/As01b/Pf37$8,312
Atorvastatin Calcium600$6,559
Rosuvastatin Calcium560$6,431
Breo ElliptaFluticasone/Vilanterol14$5,572

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$130$155,760131 claims
GSKArexvy, Trelegy Ellipta, Shingrix, Breo Ellipta, Anoro Ellipta$170$107,777282 claims
Novo NordiskRybelsus, Ozempic$97$76,72464 claims
Lilly USA, LLCMounjaro$75$25,56626 claims
AmgenProlia$150$18,49611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Gettysburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →